HighVolume Stocks Power 31 89% CAGR Strategy as Tempus Slides to 297th in Activity

On July 30, 2025, Tempus (TEM) closed with a 0.82% decline, trading at a daily volume of $420 million—a 23.26% drop from the prior day’s volume. The stock ranked 297th in trading activity among listed equities, reflecting mixed investor engagement despite its AI-driven healthcare focus.

Recent market dynamics suggest Tempus faces pressure from broader sector rotations and liquidity constraints. Analysts noted that the stock’s performance remains tied to its ability to demonstrate scalable clinical outcomes and regulatory progress. While short-term volatility persists, long-term fundamentals hinge on the company’s capacity to secure partnerships and validate its diagnostic algorithms in high-margin markets.

The strategy of buying the top 500 stocks by daily trading volume and holding them for one day yielded a 166.71% return from 2022 to the present, significantly outperforming the benchmark return of 29.18%. The strategy’s excess return was 137.53%, and it achieved a CAGR of 31.89%. This indicates a strong risk-adjusted performance and capital appreciation potential, driven by the liquidity and market sentiment around the selected stocks.